Cliff Molife

“Real‐World” Comparison of Prasugrel With Ticagrelor in Patients With Acute Coronary Syndrome Treated With Percutaneous Coronary Intervention in the United States

Cynthia Larmore, Mark B. Effron, Cliff Molife et al. · Catheterization and Cardiovascular Interventions · 2015 · 64 citations · Full text

Sequential Therapy with Ramucirumab and/or Checkpoint Inhibitors for Non-Small-Cell Lung Cancer in Routine Practice

Cliff Molife, Lisa M. Hess, Zhanglin Lin Cui et al. · Future Oncology · 2019 · 35 citations · Full text

Adherence and Persistence with Prasugrel Following Acute Coronary Syndrome with Percutaneous Coronary Intervention

Beth Nordstrom, Jason C. Simeone, Zhenxiang Zhao et al. · American Journal of Cardiovascular Drugs · 2013 · 28 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Acute Coronary Syndrome +6

One-Year Post-Discharge Resource Utilization and Treatment Patterns of Patients with Acute Coronary Syndrome Managed with Percutaneous Coronary Intervention and Treated with Ticagrelor or Prasugrel

Jason C. Simeone, Cliff Molife, Elizabeth Marrett et al. · American Journal of Cardiovascular Drugs · 2015 · 22 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Coronary Artery Disease +7

TP53 Co-Mutation Status Association with Clinical Outcomes in Patients with EGFR-Mutant Non-Small Cell Lung Cancer

Xiuning Le, Cliff Molife, Mark S. Leusch et al. · Cancers · 2022 · 22 citations · Full text